This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Thyroid Cancer
and you are
over 18
years old
4
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The study is to demonstrate non-inferior thyroid remnant first ablation success of Thyrogen and 131I compared to thyroid hormone withdrawal (THW) and 131I in patients with T4 tumour based on historical diagnostic whole body scan (DxWBS) records.

Provided treatments

  • Drug: Thyrogen
  • Drug: 131I
  • Other: Thyroid Hormone Withdrawal
Tris trial is registered with FDA with number: NCT01736163. The sponsor of the trial is Genzyme, a Sanofi Company and it is looking for 144 volunteers for the current phase.
Official trial title:
A Retrospective, Non-interventional Study of Patients With T4 Tumours Comparing the Thyroid Remnant Ablation Success Following Thyrogen and 131I Administration Versus Thyroid Hormone Withdrawal and 131I Administration